Interesting twist. However, fact of the matter is Steipp has more integrity than to try and hype a product.

Most other penny stocks would have pumped the projection just to get the share price up.

I appreciate the fact that at least Steipp hasn't falsely pumped the stock!

"I agree, cost efficient applications of amorphous alloy parts will take off. Engel's machines are important here. LQMT's IP is important!"

I would also add that Li/Eontecs cheaper bmg formula, ability for bigger BMG parts, and their ability for mass production is also important here.

I have been here for over six years, and have seen the development of this technology first hand.

We are at a very exciting point in the development and history of the company.

Understandable how past issues have created skepticism in many, but as we move forward with Li and contracts this will soon be put to rest.

I believe in the soon to be mass production of the technology! Partnering with Li/Eontec makes this both a near term possibility and reality!

Don't forget the hundreds of Engel IM machines owned by Foxconn that can be transitioned to produce bmg products, and Eontecs bmg machines!

It's only been in the last 10 months that liquidmetal has been certified, the Engel machine is perfected, and liquidmetal has been getting major exposure. These things combined with the Li deal give me optimism.

Li wouldn't be in this without the IP that liquidmetal shares with Apple.

And it also seems to me that he needs the Engel injection molding machines.

The partnership with Li, in relationship to his need for these things that belong to liquidmetal and their partners is what brings optimism.

Li wouldn't be in this if liquidmetal didn't have somthing he needs, and he says this explicitly.

It's a two way street baby!

Why are you glad?

There were no predictions from liquidmetal or MA that the knife would be mass produced!

It's important to remember the knife was produced just as the perfected Engel IM machine came out back in October of 2015.

This was more of a contract to show case a first liquidmetal product made with these new machines than a high revenue producing product.

Problem is that Steipp doesn't always communicate well to share holders, and lets speculation go wild. So when the knife didn't turn into a big revenue maker even those who were positive about the knife started calling it a failure.

Who is saying it's only about the Li deal.

Re: iateclube Post# 97286
In all of the undermining of liquidmetal, the facts of Lugee Li investing 8 million already and 54 million before Christmas is marginalized.

The fact of Engel spending their time talent and money to come up with the Injection molding machine, and then giving liquidmetal prime spotlight at their symposiums is ignored.

The fact that EONTEC is now a partner and has shared with liquidmetal their ability to produce large products from bmg and cheaper bmg, and the ability to mass produce for liquidmetal is overlooked!

These are all current happenings in the last 10 months that puts liquidmetal in a new playing field, but no mention of these facts in your post.

Oh and don't forget the IP liquidmetal shares with Apple in CIP that was the catalyst that brought Lugee Li into a partnership with liquidmetal.

Certainly we are in a better position than ever in the last 10 months to produce contracts!

In all of the undermining of liquidmetal, the facts of Lugee Li investing 8 million already and 54 million before Christmas is marginalized.

The fact of Engel spending their time talent and money to come up with the Injection molding machine, and then giving liquidmetal prime spotlight at their symposiums is ignored.

The fact that EONTEC is now a partner and has shared with liquidmetal their ability to produce large products from bmg and cheaper bmg, and the ability to mass produce for liquidmetal is overlooked!

These are all current happenings in the last 10 months that puts liquidmetal in a new playing field, but no mention of these facts in your post.

Oh and don't forget the IP liquidmetal shares with Apple in CIP that was the catalyst that brought Lugee Li into a partnership with liquidmetal.

So where in your analysis of liquidmetal do you discuss these facts!

Trying to paint a picture from the past, without dealing with these current facts about liquidmetal is very suspect, and does not paint an accurate picture of the company, its potential, its partners, it's near future.

Most of what's painted as history is nothing but tainted opinion!

The facts are Investment and partnership with Engel, EONTEC, Apple, Materion, and Li!

Soon the 54 million will be transferred, and we will be on our way up further.

Yea right. Engel insider bought a ton of liquidmetal shares because he believes it is such a huge gamble!

How about the fact that liquidmetal is a wise investment at this low price knowing the details, partners, and soon to be realized potential of this technology.

This second scenario seems to be a more legitimate and likely reason for an Engel insider to purchase shares!

"The Knife is dead. No more MA-6."

Nope. Still for sale on liquidmetal website!

Never doesn't mean it can't. Big difference!

Doesn't prove it's not ready. Could happen tomorrow for all we know.

What's for sure is Li thinks it's ready and he is backing up his posture with 64 million of his hard earned cash.

Let's see some pics of the show you said you attended.

With all the patents in CIP, Li's/Eontecs IP we now share, and everything else in the pipeline with liquidmetal, this stock is way undervalued!

I believe we will soon see a major breakout in the share price!

Liquidmetal technology limited is considered a private company, not public.

Therefore it is still considered to be a private investment. From a legal standpoint there is no difference between Li purchasing lqmt shares himself vs purchasing them through his privately owned company.

He fits into the 60 percent of 30 billion in private investments done in first half of 2016.

Do you have a link showing it's a public company vs private making the investment?

Ok now makes sense.

Nope. Private investors did the 60 percent of investing in regard to the 30 billion dollars!

So we should be just about ripe for a contract with CoNextions.

They indicated about a year for approval and moving forward with the technology at the time of the article!

Wouldn't surprise me me if we see a 2-5 million dollar repeatable contract come in soon!

60 percent of the 30 billion dollars invested in US by China in first half of 2016 is by PRIVATE INVESTORS!

Someone needs to do better D&D.

Looks like CoNextions is on the move with their Tendon Repair Technology involving Liquidmetal. Two new major hires, and nearing regulatory approval will lead to some major contracts for us soon.


CoNextions Medical Develops Breakthrough Soft Tissue Repair Technology
Share Article

Utah Firm Unveils Proprietary Device and New Procedure Designed to Substantially Improve Tendon Repair at ASSH 2015
SANDY, UTAH (PRWEB) SEPTEMBER 09, 2015
CoNextions Medical, Inc. (http://www.conextionsmed.com) announced that it will premiere their next generation tendon repair technology, CoNextions TR, at the 70th annual scientific meeting of the American Society for Surgery of the Hand (ASSH) in Seattle.
CoNextions TR has been designed to provide several advantages over the current suture-based repair which is the standard of care, including: stronger repair strength to enable early active motion; consistent and standardized outcomes; a simpler and faster surgical technique; and an improved quality of recovery for patients.
“For decades, surgeons have repaired tendons with suture-based techniques that are complex and yield unpredictable outcomes,” said Richard J. Linder, Co-founder, President and Chief Executive Officer of CoNextions Medical, a medical device company based in Sandy, Utah. “The lack of innovation in tendon repair has forced highly skilled surgeons to perform long, tedious, non-standardized and challenging surgeries with tools that have not advanced anywhere near the pace of other medical technologies,” Linder continued.
“Because of this situation,” Linder added, “every year tens of thousands of patients with hand, wrist, foot, ankle or other tendon injuries that need surgical repairs risk adverse outcomes and long rehabilitation processes that restrict their ability to work and reduce their quality of life. This is why we are so excited about the potential of CoNextions TR to both simplify surgical repairs and achieve superior clinical outcomes,” Linder concluded.
“We hand surgeons often refer to tendon repairs in Zone II as ‘no man’s land’ due to their difficulty and high complication rates,” said Melvin P. Rosenwasser, MD, the Robert E. Carroll Professor of Orthopedic Surgery and the Director of Orthopedic Hand and Orthopedic Trauma Services for the Department of Orthopedic Surgery at Columbia University in New York.
Noting that CoNextions Medical has unveiled its technology after a long period that he characterized as offering “no significant advancements” in soft tissue repair, Rosenwasser suggested that the company’s CoNextions TR “has the opportunity to completely change how hand surgeons will be taught to repair tendons,” citing specifically its projected ability to simplify historically complex surgeries.
“It’s fast, easy and strong,” concluded Rosenwasser, who is widely regarded as a leader in hand and orthopedic trauma surgery, of the repair technique made possible by the CoNextions TR.
“The CoNextions TR device allows for very strong and standardized repairs in less time than it takes to suture,” said William F. Gowski, MD, an orthopedic surgeon at The Orthopedic Specialty Hospital (TOSH) of Intermountain Healthcare in Murray, Utah and one of several surgeons who partnered with CoNextions Medical engineers to develop the technology.
“The strength of this device will increase tolerance for early active motion, which leads to less adhesion formation,” Gowski added, explaining that these post-surgical characteristics are essential to the rapid restoration of a repaired tendon’s full range of motion.
Gowski continued, “The low profile of the CoNextions TR tendon repair has strong potential to reduce triggering, a common and troubling complication,” which he described as a thickening of the flexor tendon that inhibits proper gliding of the tendon through the tendon sheath, a common complication with tendon repairs in the hand. Of the new approach made possible by CoNextions Medical, he concluded, “It also removes suturing and knot variability, which could help create consistent and standardized patient outcomes.”
“This is why we started the company,” said Erik N. Kubiak, MD, an Assistant Professor of Orthopedic Surgery at the University of Utah in Salt Lake City and CoNextions Medical’s Co-founder, Chairman of the Board and Chairman of its medical advisory board. “We founded CoNextions out of a desire to create a better quality of life for patients with tendon injuries,” noted Kubiak, “because of high complication rates, all too often patients cannot return to the full activity and mobility they enjoyed prior to injury.”
Kubiak, who provided the seminal vision for CoNextions Medical’s pioneering new soft tissue repair technology, said he takes great pride in the talented management and engineering teams that are helping him bring his company’s novel device to market. He specifically singled out the leadership provided by Co-founder and CEO Linder, a prominent figure in the local medical device and biotechnology community who also serves as Co-founder and Director of BIO-Utah, the intermountain state’s life sciences industry association.
“With his track record for turning an idea for a medical device into a market reality, I knew Rich (Linder) was the right partner to build and lead our team,” said Kubiak, explaining how the two joined forces to create CoNextions Medical.
“He’s been on the same page with me from day one: that we’re about helping people, first and foremost,” Kubiak concluded. “Because patients with tendon injuries deserve a much better shot at full recovery — a helping hand, if you will — and that’s what we’re giving them.”
CoNextions Medical, plans to seek regulatory clearance for its CoNextions TR device in the United States and other countries in the near future.
About CoNextions Medical
Founded in 2011, CoNextions Medical, Inc. is a privately held company located in Sandy, Utah. They are an innovation-based medical device company dedicated to achieving safer, stronger, and more durable tendon repairs worldwide marked by faster rehabilitation, fewer complications and lower long-term costs.
For additional information about CoNextions Medical or the CoNextions TR,
contact Angela Bailey, Senior Vice President of Marketing, at (801) 580-4049 or abailey(at)conextionsmed(dot)com.

Evidence is what has been legally submitted to the SEC in regard to the Li deal.

Negative Speculation based on the past is just that -- Speculation, not evidence!

You certainly have your right to speculate, but let's identify it for what it is- Speculation.

Cold hard facts of a legally submitted document to the SEC carry far more weight for wise investors.

Yep and as investors sell shares in hopes of .12 many will get caught with their pants down as we skyrocket into the .30s when the Li deal finalized!

I don't recall you or anyone else asking questions at the last cc.

How do you know. Link or email please.

What a joke. The guy supposedly bought 400,000 shares for a 2500 gain that he will have to pay 30 % taxes on.

Leaves him 1750.00. Big Whip doo!

What's funny is when some posters use scare tactics (like posting an article on Chinese economics) to try and get investors to sell their shares.

Chinese economy has been hurting way before the Lugee Li deal was announced, yet over 18 billion dollars in China's money has been invested in the U.S. just in the first two quarters of 2016, and this is growing in the 3rd quarter of 2016.

Over 80 percent of these Chinese investments have been calculated as real credible investments involving acquisitions, etc.

Li's/Eontecs deal with liquidmetal is a smart credible investment by Li, that will bring great success to him, his companies, and liquidmetal shareholders- Li being the largest shareholder in the company!

Don't see this going down much at all. Typical fluctuation between .15-17 during a holding pattern.

3.5 months still left in this year. A lot could happen. All real evidence points to the Li deal closing as scheduled. In addition still plenty of time to see contracts materialize from liquidmetal, Engel.

Anyone trying to trade in the interim has the right to take the EXTREME risk they take!

I am not inclined to take such risks and will continue to hold my shares long like the vast majority of share holders.

This stock is primed for a huge gain once the Li deal is confirmed, and then again as we see contracts confirmed!

Good luck to all true longs!

Hope implies expectation!

I am long and I am in the green.

This company is trying to develop a disruptive technology so it's natural to expect dips in the road.

The key is to purchase shares when there is a dip and hold it, rather than sell at the next small pop.

I like all the positive irons in the fire with this company, and believe this long term investment will pay off big.

There is a lot of excitement in this stock right now over the Chinese investor, EONTEC, Engel, all the new patents from Apple, a potential Apple 2017 iPhone, CoNextions contract, and others coming soon.

Remember the key is to buy low and hold!

Please explain how .18 will cause a Visser flood.

Vissers exercise/purchase price is .18 on which he will have to pay taxes.

Do you really think he will try and sell shares at the same price he just paid for them plus taxes?

Please explain, because this makes absolutely no logical sense.

Great info! Thanks for bringing it to the board!

Apple is tumbling while liquidmetal heads into the green!

Like I said before the Apple conference, liquidmetal will continue to head upward.

Shorts found this out the hard way.

Our Chinese investors 54 million, anticipated leaks of a liquidmetal iPhone 8, and contracts will all send our stock into the low dollars!

I had to laugh at the 11.5 cent prediction for this week!

All eyes will turn toward a liquidmetal iPhone 8 over the next 363 days!

It's not just the ceramic watch. It's also the pressure sensitive home button that has the patent for liquidmetal. Therefore it's a given this is made from liquidmetal.

Someone needs to write an article and shout this from the roof tops!

Looks like a sure thing for the liquidmetal pressure sensitive home button!

Just a matter of whether Cook announces that it's made with liquidmetal or if we have to wait for an October tear down!

The good news about liquidmetals current state is we have both Apple, and Li/EONTEC.

Regardless of what news we receive today, the combination of a 2017 liquidmetal iPhone, and Li's huge investment/partnership with liquidmetal (do to close any day) will ultimately keep our company and share price moving upward!

http://www.patentlyapple.com/patently-apple/2016/09/apple-wins-patent-for-a-mobile-phone-encased-in-a-glass-embodiment.html

34,000 but 200,000 in billings for April-June.

We now have 3rd quarter July-September. Production for Apple phones doesn't even start until mid-August.

Still ample room and time for a major increase in 3rd quarter & 4th quarter revenues for both Eontec and Liquidmetal.

The revised home button Liquidmetal patent seems to be a sure thing in the September 7 iPhone.

Those sitting on the sideline will be in for a nice surprise as they see LQMT/EONTEC share price take a nice spike up!

This is all just the beginning!

These guys are confident of the FDA APPROVAL soon.

Two major hires in the last month says it all.

I believe we are going to see a major contract and revenue soon with this partnership with CoNextions!

Very exciting!